Binding constructs and methods for use thereof

Details Binding constructs and methods for use thereof Binding constructs and methods for use thereof

2003-07-26

2010-11-09

Bristol, Lynn (Department: 1643)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C530S387300

Reexamination Certificate

active

07829084

ABSTRACT:
The invention relates to novel binding domain-immunoglobulin fusion proteins that feature a binding domain for a cognate structure such as an antigen, a counterreceptor or the like, a wild-type IgG1, IGA or IgE hinge-acting region, i.e., IgE CH2, region polypeptide or a mutant IgG1 hinge region polypeptide having either zero, one or two cysteine residues, and immunoglobulin CH2 and CH3 domains, and that are capable of ADCC and/or CDC while occurring predominantly as polypeptides that are compromised in their ability to form disulfide-linked multimers. The fusion proteins can be recombinantly produced at high expression levels. Also provided are related compositions and methods, including cell surface forms of the fusion proteins and immunotherapeutic applications of the fusion proteins and of polynucleotides encoding such fusion proteins.

REFERENCES:
patent: 4704692 (1987-11-01), Ladner
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4906562 (1990-03-01), Hellstrom et al.
patent: 4935495 (1990-06-01), Hellstrom et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5091177 (1992-02-01), Hellstrom et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5225539 (1993-07-01), Winter
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5455030 (1995-10-01), Ladner et al.
patent: 5500362 (1996-03-01), Robinson et al.
patent: 5521288 (1996-05-01), Linsley et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5580756 (1996-12-01), Linsley et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5597707 (1997-01-01), Marken et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5637481 (1997-06-01), Ledbetter et al.
patent: 5645835 (1997-07-01), Fell, Jr. et al.
patent: 5677425 (1997-10-01), Bodmer et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5709859 (1998-01-01), Aruffo et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5736137 (1998-04-01), Rastetter et al.
patent: 5770197 (1998-06-01), Linsley et al.
patent: 5773253 (1998-06-01), Linsley et al.
patent: 5776456 (1998-07-01), Rastetter et al.
patent: 5795572 (1998-08-01), Diegel et al.
patent: 5807734 (1998-09-01), Diegel et al.
patent: 5844093 (1998-12-01), Kettleborough et al.
patent: 5844095 (1998-12-01), Linsley et al.
patent: 5869049 (1999-02-01), Noelle et al.
patent: 5869620 (1999-02-01), Whitlow et al.
patent: 5876718 (1999-03-01), Noelle et al.
patent: 5876950 (1999-03-01), Siadak et al.
patent: 5888773 (1999-03-01), Jost et al.
patent: 5892019 (1999-04-01), Schlom et al.
patent: 5916560 (1999-06-01), Larsen et al.
patent: 6015695 (2000-01-01), Casterman et al.
patent: 6074644 (2000-06-01), Pastan et al.
patent: 6087329 (2000-07-01), Armitage et al.
patent: 6090914 (2000-07-01), Linsley et al.
patent: 6147203 (2000-11-01), Pastan et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6194551 (2001-02-01), Idusogie et al.
patent: 6264951 (2001-07-01), Armitage et al.
patent: 6284536 (2001-09-01), Morrison et al.
patent: 6312692 (2001-11-01), Noelle et al.
patent: 6376459 (2002-04-01), Aruffo et al.
patent: 6384198 (2002-05-01), Diegel et al.
patent: 6403769 (2002-06-01), Larochelle et al.
patent: 6410319 (2002-06-01), Raubitschek et al.
patent: 6444792 (2002-09-01), Gray et al.
patent: 6472510 (2002-10-01), Aruffo et al.
patent: 6482919 (2002-11-01), Ledbetter et al.
patent: 6623940 (2003-09-01), Ledbetter et al.
patent: 6641809 (2003-11-01), Linsley et al.
patent: 6815540 (2004-11-01), Pluckthun et al.
patent: 2001/0044135 (2001-11-01), Stahi et al.
patent: 2002/0031510 (2002-03-01), Larsen et al.
patent: 2002/0039557 (2002-04-01), White
patent: 2002/0155604 (2002-10-01), Ledbetter et al.
patent: 2003/0219433 (2003-02-01), Hansen et al.
patent: 2003/0044423 (2003-03-01), Gillies et al.
patent: 2003/0088074 (2003-05-01), Hamers et al.
patent: 2003/0118592 (2003-06-01), Ledbetter et al.
patent: 2003/0133930 (2003-07-01), Goldenberg et al.
patent: 2003/0219436 (2003-11-01), Ledbetter et al.
patent: 2003/0219446 (2003-11-01), Linsley et al.
patent: 2003/0219876 (2003-11-01), Ledbetter et al.
patent: 2004/0058445 (2004-03-01), Ledbetter et al.
patent: 0274394 (1988-07-01), None
patent: 0 555 880 (1993-08-01), None
patent: 0586002 (1994-03-01), None
patent: 0 757 099 (1995-07-01), None
patent: 0 682 039 (1995-11-01), None
patent: 1 186 300 (2002-03-01), None
patent: WO 89/07142 (1989-08-01), None
patent: WO 92/00092 (1992-01-01), None
patent: WO9221755 (1992-12-01), None
patent: WO 93/00431 (1993-01-01), None
patent: WO 94/04678 (1994-03-01), None
patent: WO9405690 (1994-03-01), None
patent: WO 94/25591 (1994-11-01), None
patent: WO9509917 (1995-04-01), None
patent: WO 96/34103 (1996-10-01), None
patent: WO-98/02462 (1998-01-01), None
patent: WO 99/42077 (1999-08-01), None
patent: WO0044777 (2000-08-01), None
patent: WO-02/056910 (2002-07-01), None
patent: WO-02/072605 (2002-09-01), None
patent: 2004/003019 (2004-08-01), None
Print-out of PubMed search for “des-leucine” (p. 1).
Campbell et al, Biology, 5th ed. p. 856, 1999.
Search output from ATCC website for hybridomas: 2H7 (pp. 1-2), 1D8 (p. 1) , HD37 (p. 1), G28-1 (p. 1), 4.4.220 (p. 1), Fc2-2 (p. 1), UCHL-1 (p. 1), 5B9 (p. 1), L6 (p. 1), 10A8 (p. 1), 2e12 (p. 1), 40.2.36 (p. 1) and G19-4 (p. 1).
Burgess et al, Journal of Cell Biology vol. 111 Nov. 1990 2129-2138).
Lazar et al Molecular and Cellular Biology Mar. 1988 vol. 8 No. 3 1247-1252.
Schwartz et al, Proc Natl Acad Sci USA vol. 84:6408-6411 (1987).
Lin et al Biochemistry USA vol. 14:1559-1563 (1975).
Worn and Pluckthun (J. Mol. Biol. 305:989-1010 (2001).
Hollinger and Hudson (Nature Biotech. 23:1126-1136 (2005).
Roux et al. (J. Immunol. 161:4083-4090 (1998).
Damle et al.. Eur. J. Immunol. 21:1277-1282 (1991).
Ward et al. Nature 341:544-546 (1989); Abstract.
Nutall et al., Curr. Pharm. Bitechnol. 1:253-263 (2000).
Muyldermans, J. Biotechnol. 74:277-302 (2001), Abstract.
Pascalis et al. (The Journal of Immunology (2002) 169, 3076-3084).
MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).
Casset et al. (2003) BBRC 307, 198-205.
Vajdos et al. (2002) J. Mol. Biol. 320, 415-428.
Holm et al (2007) Mol. Immunol. 44: 1075-1084.
Chen et al. J. Mol. Bio. (1999) 293, 865-881.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
Brummell et al. (Biochemistry 32:1180-1187 (1993)).
Kobayashi et al. (Protein Engineering 12:879-844 (1999)).
Burks et al. (PNAS 94:412-417 (1997)).
Jang et al. (Molec. Immunol. 35:1207-1217 (1998)).
Brorson et al. (J. Immunol. 163:6694-6701 (1999)).
Coleman (Research in Immunol. 145:33-36 (1994)).
IUPAC -IUB Commission (J. Biol. Chem. 242:555-557 (1967)).
Welschof et al. (Human Immunol. 60:282-290 (1990)).
Ledbetter et al. (U.S. Appl. No. 12/371,467; not yet published; Assignee: Trubion; filed Feb. 13, 2009).
Ward et al. (Nature 341:544-546 (1989)).
Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).
Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).
Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).
U.S. Appl. No. 09/590,284, filed Jun. 9, 2000, Goldenberg et al.
Munoz E. et The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3. Int Immunol. Feb. 1998;10(2):97-106.
Martin S. et al., Efficient neutralization and disruption of rhinovirus by chimeric ICAM- 1/immunoglobulin molecules , J. Virol. 1993,67:3561-3568.
Stevenson G.T. et al., Mechanisms in removal of tumor by antibody. Cell Biophys. 1994;24-25:45-50.
Anderson et al., Targeted anti-cancer therapy using rituximab, a chimeric anti-CD-20 antibody (IDEC-c2B8) in the treatment of non-hodgkin's B-cell lymphoma; Biochemical Society Transactions Colcester, Essex, GB, pp. 705-708; 1997.
Cruse et al., “Illustrated Dictionary of Immunology”, CRC Press, 1995, p. 157.
Paul, “Fudamental Immunology”, Raven Press, 1993, Chp. 8, p. 242.
Rudikoff et al., “Single amino acid substitution altering antigen-binding specificity”, Proc Natl Acad Sci U S A, Mar. 1982, 79(6):1979-83.
Wang et al., “Human single-chain FV immunoconjugates targeted to

Affiliated with

Also associated with

Rating

Binding constructs and methods for use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Binding constructs and methods for use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding constructs and methods for use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4251590